Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Holman

Showing results (681-690 of 716) with videos related to

Pageof 72
Sort By:
The New England Journal of Medicine|June 9, 2015
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 DiabetesJennifer B Green, M Angelyn Bethel, Paul W Armstrong, et al.
Cell|May 13, 2014
A proliferative burst during preadolescence establishes the final cardiomyocyte numberNawazish Naqvi, Ming Li, John W Calvert, et al.
Journal of the American Heart Association|October 30, 2018
Effect of Once-Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL TrialRobert J Mentz, M Angelyn Bethel, Peter Merrill, et al.
American Heart Journal|March 21, 2016
Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trialRury R Holman, Mary Angelyn Bethel, Jyothis George, et al.
Circulation|January 30, 2020
Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future DirectionsAbhinav Sharma, Neha J Pagidipati, Robert M Califf, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Rapid assessment of changes in phage bioactivity using dynamic light scatteringTejas Dharmaraj, Michael J Kratochvil, Julie D Pourtois, et al.
Diabetologia|August 10, 2012
Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trialsR J Stevens, R Ali, C R Bankhead, et al.
PNAS Nexus|December 19, 2023
Rapid assessment of changes in phage bioactivity using dynamic light scatteringTejas Dharmaraj, Michael J Kratochvil, Julie D Pourtois, et al.
The Lancet. Diabetes & Endocrinology|September 18, 2017
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trialRury R Holman, Ruth L Coleman, Juliana C N Chan, et al.
Science Advances|January 20, 2023
A tissue atlas of ulcerative colitis revealing evidence of sex-dependent differences in disease-driving inflammatory cell types and resistance to TNF inhibitor therapyAaron T Mayer, Derek R Holman, Anav Sood, et al.
Pageof 72

Showing results (681-690 of 716) with videos related to

Sort By:
Pageof 72
The New England Journal of Medicine|June 9, 2015
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 DiabetesJennifer B Green, M Angelyn Bethel, Paul W Armstrong, et al.
Cell|May 13, 2014
A proliferative burst during preadolescence establishes the final cardiomyocyte numberNawazish Naqvi, Ming Li, John W Calvert, et al.
Journal of the American Heart Association|October 30, 2018
Effect of Once-Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL TrialRobert J Mentz, M Angelyn Bethel, Peter Merrill, et al.
American Heart Journal|March 21, 2016
Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trialRury R Holman, Mary Angelyn Bethel, Jyothis George, et al.
Circulation|January 30, 2020
Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future DirectionsAbhinav Sharma, Neha J Pagidipati, Robert M Califf, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Rapid assessment of changes in phage bioactivity using dynamic light scatteringTejas Dharmaraj, Michael J Kratochvil, Julie D Pourtois, et al.
Diabetologia|August 10, 2012
Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trialsR J Stevens, R Ali, C R Bankhead, et al.
PNAS Nexus|December 19, 2023
Rapid assessment of changes in phage bioactivity using dynamic light scatteringTejas Dharmaraj, Michael J Kratochvil, Julie D Pourtois, et al.
The Lancet. Diabetes & Endocrinology|September 18, 2017
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trialRury R Holman, Ruth L Coleman, Juliana C N Chan, et al.
Science Advances|January 20, 2023
A tissue atlas of ulcerative colitis revealing evidence of sex-dependent differences in disease-driving inflammatory cell types and resistance to TNF inhibitor therapyAaron T Mayer, Derek R Holman, Anav Sood, et al.
Pageof 72